This month we are featuring three new blog posts that are on the cutting edge of preclinical science. These in depth articles showcase how TransCure's humanized models can be utilized in your research for specific diseases. We hope you find them of interest.
Liver cancer, specifically hepatocellular carcinoma (HCC), stands as a major global health concern, ranking as the sixth most prevalent cancer and the fourth leading cause of cancer-related mortality.
The development of curative therapies is a crucial issue for the future management of Non-Alcoholic Liver Disease (NAFLD), and the success of this endeavor is highly dependent of our propensity to gain a deeper understanding of this pathology.
Non-alcoholic liver disease (NAFLD) is the most prevalent chronic liver disease worldwide, affecting more than a third of the global population and increasing rapidly, alongside the global epidemic of obesity and related metabolic diseases.
